Pubrica


The American Journal of Clinical Oncology (AJCO) is a well-established, peer-reviewed journal dedicated to advancing clinical cancer research and oncology practice. It serves as an important platform for publishing high-quality studies that address the prevention, diagnosis, and treatment of cancer across multiple clinical disciplines.

AJCO provides clinicians and researchers with rigorous, evidence-based research focused on multidisciplinary cancer management, including clinical trials, translational research, treatment outcomes, and emerging therapeutic approaches. By promoting integration across medical, surgical, and radiation oncology, the journal supports evidence-based decision-making and continued progress in comprehensive cancer care.

American Journal of Clinical Oncology

The American Journal of Clinical Oncology (AJCO) is a well-established, peer-reviewed journal dedicated to advancing clinical cancer research and oncology practice. It serves as an important platform for publishing high-quality studies that address the prevention, diagnosis, and treatment of cancer across multiple clinical disciplines.

AJCO provides clinicians and researchers with rigorous, evidence-based research focused on multidisciplinary cancer management, including clinical trials, translational research, treatment outcomes, and emerging therapeutic approaches. By promoting integration across medical, surgical, and radiation oncology, the journal supports evidence-based decision-making and continued progress in comprehensive cancer care.

Aim and Scope

The American Journal of Clinical Oncology is a multidisciplinary, peer-reviewed journal serving cancer surgeons, radiation oncologists, medical oncologists, gynaecologic oncologists, and related oncology specialists. The journal aims to publish high-quality research that advances the combined-modality and multidisciplinary management of cancer, with a strong emphasis on clinical relevance and evidence-based practice.

AJCO gives priority to manuscripts reporting rigorous clinical and translational research that improves understanding of cancer treatment strategies and patient outcomes. The journal highlights advance in translational oncology, outcomes research, cancer-related health policy, and cost-utility analyses that inform clinical decision-making and oncology care delivery. Select review articles and expert opinion pieces are also included to provide context and perspective on emerging issues in oncology. Case reports are not considered for publication.

Scope of the Journal includes:

  • Multidisciplinary and combined-modality cancer management
  • Clinical oncology research across surgical, medical, radiation, and gynaecologic oncology
  • Translational research with direct clinical applicability
  • Outcomes research and comparative effectiveness studies
  • Cancer-related health policy and health services research
  • Cost-utility and economic analyses in oncology
  • Expert reviews and opinion articles on contemporary oncology practice

AJCO publishes Original Research Articles, Review Articles, and invited opinion pieces. All submissions undergo rigorous peer review. The journal is guided by an internationally recognized Editorial Board composed of leading experts across oncology disciplines, ensuring scientific quality, clinical relevance, and scholarly integrity.

Our comprehensive publication services are designed to support authors targeting high-impact oncology journals such as the American Journal of Clinical Oncology. We offer end-to-end oncology journal submission assistance, tailored multidisciplinary oncology research support, and expert oncology manuscript publication support to help researchers navigate every stage of the publishing process. From precise clinical oncology manuscript editing services to advanced multidisciplinary oncology research editing, our team ensures scientific clarity, journal compliance, and clinical relevance. We also provide dedicated oncology peer review response support, helping authors address reviewer feedback with confidence and improve their chances of successful publication.

American journal of clinical oncology

American Journal of Clinical Oncology

Impact Factor

Impact Factor

1.372

SJR (SCImago Journal Rank)

SJR (SCImago Journal Rank)

0.696

CiteScore

CiteScore

3.1

Frequency

Frequency

12 issues per year (Monthly)

Submission to Acceptance

Publisher

Wolters Kluwer

Acceptance Rate

Acceptance Rate

NA

Key Highlights

5 Year Impact Factor

3.1

H Index

93

Indexing

PubMed, MEDLINE, Scopus, Index Medicus, Science Citation Index Expanded (SCIE), Current Contents/Clinical Medicine, BIOSIS Previews, Embase, Excerpta Medica, and EBSCOhost

Initial Editorial Decision

1–2 weeks

First Post Review Decision

4 weeks

Submission to Acceptance

Generally, within a few months

Acceptance to Publication

NA

Publication Type

Original Articles, Review Articles, Case reports, Editorial and commentaries.

Acceptance Rate

19%

Open Access Model

Hybrid (traditional subscription-based, with an optional open access fee for immediate, permanent free access).

Article Processing Charges

$2,200–$2,500+ depending on the license type (CC BY or CC BY-NC-ND)

Main Text

3,500 to 5,000 words

Abstract

200 words, structured format.

References

60–150 references

Tables/Figures

A strict limit of 6 or 7 combined figures and tables is common for original reports.